Gritstone Bio Can Tap $25M New DIP As It Works Toward Sale

By Alex Wittenberg · November 13, 2024, 4:27 PM EST

Vaccine developer Gritstone bio Inc. won a Delaware bankruptcy judge's approval Wednesday to borrow $25 million in new financing to support itself in Chapter 11 as the biotechnology company works to...

To view the full article, register now.